Senior insider sale
EVP R&D, Chief Medical Officer at ALKERMES PLC. — senior position signals high conviction
$2.59M
63K shares
HOPKINSON CRAIG C. plans to sell 63K shares of ALKERMES PLC. valued at approximately $2.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of employee stock options
Broker assisted cashless exercise
Vesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
Vesting of performance share award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Exercise of employee stock options Broker assisted cashless exercise | 5K | — |
2/23/2026 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 2.10K | — |
2/5/2026 | Vesting of performance share award Granted as part of issuer equity compensation plan | 1.90K | — |
| Total | 9K | ||
Completed
Units to sell
9K
Market value
$437.2K
Units to sell
9K
Market value
$463.6K
Units to sell
9K
Market value
$375.0K
Units to sell
9K
Market value
$300.6K
Units to sell
9K
Market value
$319.6K
Units to sell
9K
Market value
$267.5K
Planned — Approximate Date
Units to sell
9K
Market value
$422.9K
Units
63K
Value
$2.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 9K | $437.2K | — | Completed |
7/1/2026 | 9K | $463.6K | — | Completed |
6/1/2026 | 9K | $375.0K | — | Completed |
5/1/2026 | 9K | $300.6K | — | Completed |
4/1/2026 | 9K | $319.6K | — | Completed |
3/2/2026 | 9K | $267.5K | — | Completed |
| Planned — Approximate Date | ||||
9/1/2026 | 9K | $422.9K | NASDAQ | Planned |
| Total | 63K | $2.59M | ||